CMS Approves D.C. Waiver For Substance Use, Mental Illness Treatment

By Chelsea Cirruzzo / November 6, 2019 at 10:45 AM
CMS announced Wednesday (Nov. 6) that it approved a waiver to allow District of Columbia to sidestep a restriction on using Medicaid dollars to fund inpatient treatment for substance use and mental illness. The waiver is the first time CMS approved a waiver to use Medicaid funding for the treatment of serious mental illness in conjunction with substance use treatment. The Institutions for Mental Diseases (IMD) exclusion bars Medicaid from funding patients’ stays in mental institutions with more than 16...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.